CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale Chief Legal Officer sold 49,962 shares at an average $0.90 ($44,800)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief R&D Officer sold 51,115 shares at $0.94 ($48,048)
- 4 Open-market sale President & CEO sold 132,030 shares at an average $1.00 ($131,650)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award Chief R&D Officer acquired 135,000 shares (grant or award)
Page 9 of 100 · 1,982 filings